Rene Georg Ott currently serves as the Global Head of Small Molecules Breast at AstraZeneca, leading initiatives aimed at eliminating breast cancer as a cause of death through innovative medical strategies. Their prior roles include impactful leadership positions within AstraZeneca's Global Medical Affairs and Oncology divisions, where they successfully drove product launches and strategic alignment across multiple regions. Rene's extensive experience in the pharmaceutical industry is complemented by their education in Oncology, Immunology, and Business Administration, including PhD and Executive MBA qualifications. They previously contributed to research at institutions such as The Rockefeller University and Boehringer Ingelheim, shaping the future of oncology treatments.
This person is not in the org chart
This person is not in any teams
This person is not in any offices